LBT Innovations Ltd
Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. The company offers Automated Plate Assessment System (APAS) Independence, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for mi… Read more
LBT Innovations Ltd (LBT) - Net Assets
Latest net assets as of June 2024: AU$2.42 Million AUD
Based on the latest financial reports, LBT Innovations Ltd (LBT) has net assets worth AU$2.42 Million AUD as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$7.93 Million) and total liabilities (AU$5.51 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | AU$2.42 Million |
| % of Total Assets | 30.55% |
| Annual Growth Rate | -3.4% |
| 5-Year Change | -89.95% |
| 10-Year Change | -84.55% |
| Growth Volatility | 156.95 |
LBT Innovations Ltd - Net Assets Trend (2005–2024)
This chart illustrates how LBT Innovations Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for LBT Innovations Ltd (2005–2024)
The table below shows the annual net assets of LBT Innovations Ltd from 2005 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-06-30 | AU$2.42 Million | +2407.62% |
| 2023-06-30 | AU$-105.00K | -100.49% |
| 2022-06-30 | AU$21.34 Million | -14.25% |
| 2021-06-30 | AU$24.88 Million | +3.19% |
| 2020-06-30 | AU$24.11 Million | -18.31% |
| 2019-06-30 | AU$29.52 Million | +1.41% |
| 2018-06-30 | AU$29.11 Million | +36.07% |
| 2017-06-30 | AU$21.39 Million | +11.48% |
| 2016-06-30 | AU$19.19 Million | +22.35% |
| 2015-06-30 | AU$15.68 Million | +15.63% |
| 2014-06-30 | AU$13.56 Million | +5.56% |
| 2013-06-30 | AU$12.85 Million | +4.37% |
| 2012-06-30 | AU$12.31 Million | -8.58% |
| 2011-06-30 | AU$13.47 Million | -8.24% |
| 2010-06-30 | AU$14.68 Million | +10.89% |
| 2009-06-30 | AU$13.24 Million | +2.72% |
| 2008-06-30 | AU$12.89 Million | +6.17% |
| 2007-06-30 | AU$12.14 Million | +666.26% |
| 2006-06-30 | AU$1.58 Million | -66.14% |
| 2005-06-30 | AU$4.68 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to LBT Innovations Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5245071700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (June 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | AU$53.11 Million | 2191.75% |
| Other Comprehensive Income | AU$2.09 Million | 86.13% |
| Total Equity | AU$2.42 Million | 100.00% |
LBT Innovations Ltd Competitors by Market Cap
The table below lists competitors of LBT Innovations Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PlexBio Co., Ltd.
TWO:6572
|
$8.39 Million |
|
SY PUBLIC UTIL -H- (SH3.SG)
STU:SH3
|
$8.39 Million |
|
Beauty Skin Corp.
KQ:406820
|
$8.39 Million |
|
Texmo Pipes and Products Limited
NSE:TEXMOPIPES
|
$8.39 Million |
|
Apollo Silver Corp
OTCQB:APGOF
|
$8.38 Million |
|
Infrared Cameras Holdings Inc
NASDAQ:MSAI
|
$8.38 Million |
|
Solueta Co Ltd
KQ:154040
|
$8.38 Million |
|
General Environmental Management Inc
PINK:GEVI
|
$8.38 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in LBT Innovations Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -105,000 to 2,423,000, a change of 2,528,000.
- Net loss of 3,740,000 reduced equity.
- Share repurchases of 543,000 reduced equity.
- New share issuances of 6,123,000 increased equity.
- Other comprehensive income increased equity by 140,000.
- Other factors increased equity by 548,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | AU$-3.74 Million | -154.35% |
| Share Repurchases | AU$543.00K | -22.41% |
| Share Issuances | AU$6.12 Million | +252.7% |
| Other Comprehensive Income | AU$140.00K | +5.78% |
| Other Changes | AU$548.00K | +22.62% |
| Total Change | AU$- | % |
Book Value vs Market Value Analysis
This analysis compares LBT Innovations Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 6.58x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.24x to 6.58x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-06-30 | AU$0.07 | AU$0.02 | x |
| 2007-06-30 | AU$0.11 | AU$0.02 | x |
| 2008-06-30 | AU$0.13 | AU$0.02 | x |
| 2009-06-30 | AU$0.13 | AU$0.02 | x |
| 2010-06-30 | AU$0.15 | AU$0.02 | x |
| 2011-06-30 | AU$0.14 | AU$0.02 | x |
| 2012-06-30 | AU$0.12 | AU$0.02 | x |
| 2013-06-30 | AU$0.09 | AU$0.02 | x |
| 2014-06-30 | AU$0.14 | AU$0.02 | x |
| 2015-06-30 | AU$0.14 | AU$0.02 | x |
| 2016-06-30 | AU$0.17 | AU$0.02 | x |
| 2017-06-30 | AU$0.12 | AU$0.02 | x |
| 2018-06-30 | AU$0.13 | AU$0.02 | x |
| 2019-06-30 | AU$0.10 | AU$0.02 | x |
| 2020-06-30 | AU$0.07 | AU$0.02 | x |
| 2021-06-30 | AU$0.06 | AU$0.02 | x |
| 2022-06-30 | AU$0.05 | AU$0.02 | x |
| 2023-06-30 | AU$0.00 | AU$0.02 | x |
| 2024-06-30 | AU$0.00 | AU$0.02 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently LBT Innovations Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -154.35%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -297.77%
- • Asset Turnover: 0.16x
- • Equity Multiplier: 3.27x
- Recent ROE (-154.35%) is below the historical average (-13.93%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 7.95% | 28.44% | 0.20x | 1.37x | AU$-248.42K |
| 2008 | 5.60% | 38.65% | 0.10x | 1.52x | AU$-566.60K |
| 2009 | 2.55% | 16.92% | 0.10x | 1.50x | AU$-986.70K |
| 2010 | 10.14% | 39.41% | 0.18x | 1.44x | AU$20.20K |
| 2011 | -8.63% | -232.40% | 0.03x | 1.47x | AU$-2.51 Million |
| 2012 | -9.39% | -137.29% | 0.05x | 1.49x | AU$-2.39 Million |
| 2013 | 4.13% | 12.24% | 0.23x | 1.46x | AU$-754.00K |
| 2014 | 2.15% | 7.32% | 0.18x | 1.65x | AU$-1.06 Million |
| 2015 | 2.05% | 13.56% | 0.10x | 1.57x | AU$-1.25 Million |
| 2016 | 18.64% | 46.30% | 0.26x | 1.53x | AU$1.66 Million |
| 2017 | -23.99% | -1555.45% | 0.01x | 1.42x | AU$-7.27 Million |
| 2018 | -9.22% | -282.33% | 0.03x | 1.24x | AU$-5.60 Million |
| 2019 | -14.74% | -1454.85% | 0.01x | 1.29x | AU$-7.30 Million |
| 2020 | -23.37% | -485.03% | 0.03x | 1.40x | AU$-8.05 Million |
| 2021 | -29.18% | -646.48% | 0.03x | 1.43x | AU$-9.75 Million |
| 2022 | -31.13% | -312.08% | 0.07x | 1.48x | AU$-8.77 Million |
| 2023 | 0.00% | -1056.47% | 0.29x | 0.00x | AU$-22.51 Million |
| 2024 | -154.35% | -297.77% | 0.16x | 3.27x | AU$-3.98 Million |
Industry Comparison
This section compares LBT Innovations Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $14,750,885
- Average return on equity (ROE) among peers: -315.19%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| LBT Innovations Ltd (LBT) | AU$2.42 Million | 7.95% | 2.27x | $8.39 Million |
| 4DMEDICAL Ltd (4DX) | $926.64K | -85.93% | 0.18x | $1.03 Billion |
| Adherium Ltd (ADR) | $34.53 Million | -3.63% | 0.08x | $2.37 Million |
| Aroa Biosurgery Ltd (ARX) | $-22.65 Million | 0.00% | 0.00x | $92.74 Million |
| Atomo Diagnostics Ltd (AT1) | $34.48 Million | -26.73% | 0.05x | $8.96 Million |
| Control Bionics Ltd (CBL) | $6.09 Million | -15.97% | 0.04x | $4.98 Million |
| Cardiex Ltd (CDX) | $3.03 Million | -101.61% | 0.73x | $4.25 Million |
| Compumedics Ltd (CMP) | $9.21 Million | -30.70% | 1.16x | $13.08 Million |
| Cochlear Ltd (COH) | $75.42 Million | 53.19% | 1.13x | $7.01 Billion |
| Cleo Diagnostics Ltd (COV) | $5.83 Million | -68.54% | 0.19x | $23.47 Million |
| Conneqt Health Limited (CQT) | $633.50K | -2871.98% | 13.72x | $4.66 Million |